Association of dipeptidyl peptidase‐4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability

Documenti analoghi

• Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model
  di: Phil McEwan, et al.
  Pubblicazione: (2025)
• Association between glycated haemoglobin A 1c and total haemoglobin mass in adults with type 1 diabetes mellitus. A proof‐of‐concept study
  di: Janis Schierbauer, et al.
  Pubblicazione: (2025)
• Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada
  di: Tina Kim, et al.
  Pubblicazione: (2024)
• Change in glycated haemoglobin in adults with type 2 diabetes on basal‐bolus insulin regimens following commencement of Freestyle Libre use
  di: Anna R. Dover, et al.
  Pubblicazione: (2024)
• Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study
  di: Jingqi Yang, et al.
  Pubblicazione: (2024)